Announcements

Editor's Choice Articles are selected based on suggestions from Cancers’ Academic Editors worldwide. The Editors select a small number of recently published articles that they consider particularly interesting to our readers or important in their respective fields of research. You are welcome to read the Editor's Choice Articles related to molecular cancer biology, a curated list of high-quality articles from 2022 to 2023 in Cancers (ISSN: 2072-6694). The list of relevant papers can be seen below. The full list of Editor's Choice Articles can be viewed at the following link: https://www.mdpi.com/journal/cancers/editors_choice.

“The Roles of microRNAs in Cancer Multidrug Resistance”
by Lucia Pavlíková, Mário Šereš, Albert Breier and Zdena Sulová
Cancers 2022, 14(4), 1090; https://doi.org/10.3390/cancers14041090
Available online: https://www.mdpi.com/2072-6694/14/4/1090

“Lung Adenocarcinoma Tumor Origin: A Guide for Personalized Medicine”
by Laetitia Seguin, Manon Durandy and Chloe C. Feral
Cancers 2022, 14(7), 1759; https://doi.org/10.3390/cancers14071759
Available online: https://www.mdpi.com/2072-6694/14/7/1759

“Direct Targeting KRAS Mutation in Non-Small Cell Lung Cancer: Focus on Resistance”
by Damien Reita, Lucile Pabst, Erwan Pencreach, Eric Guérin, Laurent Dano, Valérie Rimelen, Anne-Claire Voegeli, Laurent Vallat, Céline Mascaux and Michèle Beau-Faller
Cancers 2022, 14(5), 1321; https://doi.org/10.3390/cancers14051321
Available online: https://www.mdpi.com/2072-6694/14/5/1321

“The Role of TP53 Mutations in EGFR-Mutated Non-Small-Cell Lung Cancer: Clinical Significance and Implications for Therapy”
by Matteo Canale, Kalliopi Andrikou, Ilaria Priano, Paola Cravero, Luigi Pasini, Milena Urbini, Angelo Delmonte, Lucio Crinò, Giuseppe Bronte and Paola Ulivi
Cancers 2022, 14(5), 1143; https://doi.org/10.3390/cancers14051143  
Available online: https://www.mdpi.com/2072-6694/14/5/1143

“Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives”
by Nora Berois, Alvaro Pittini and Eduardo Osinaga
Cancers 2022, 14(3), 645; https://doi.org/10.3390/cancers14030645  
Available online: https://www.mdpi.com/2072-6694/14/3/645

“Upregulation of CD36, a Fatty Acid Translocase, Promotes Colorectal Cancer Metastasis by Increasing MMP28 and Decreasing E-Cadherin Expression”
by James Drury, Piotr G. Rychahou, Courtney O. Kelson, Mariah E. Geisen, Yuanyuan Wu, Daheng He, Chi Wang, Eun Y. Lee, B. Mark Evers, and Yekaterina Y. Zaytseva
Cancers 2022, 14(1), 252; https://doi.org/10.3390/cancers14010252  
Available online: https://www.mdpi.com/2072-6694/14/1/252

“Harnessing Antitumor CD4⁺ T Cells for Cancer Immunotherapy”
by Myriam Ben Khelil, Yann Godet, Syrine Abdeljaoued, Christophe Borg, Olivier Adotévi and Romain Loyon
Cancers 2022, 14(1), 260; https://doi.org/10.3390/cancers14010260  
Available online: https://www.mdpi.com/2072-6694/14/1/260

“Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer”
by Roberto Corchado-Cobos, Natalia García-Sancha, Marina Mendiburu-Eliçabe, Aurora Gómez-Vecino, Alejandro Jiménez-Navas, Manuel Jesús Pérez-Baena, Marina Holgado-Madruga, Jian-Hua Mao, Javier Cañueto, Sonia Castillo-Lluva et al.
Cancers 2022, 14(2), 322; https://doi.org/10.3390/cancers14020322  
Available online: https://www.mdpi.com/2072-6694/14/2/322

“A Breakthrough Brought about by Targeting KRAS^G12C: Nonconformity Is Punished”
by Wenjuan Ning, Zhang Yang, Gregor J. Kocher, Patrick Dorn and Ren-Wang Peng
Cancers 2022, 14(2), 390; https://doi.org/10.3390/cancers14020390  
Available online: https://www.mdpi.com/2072-6694/14/2/390

“Biglycan Promotes Cancer Stem Cell Properties, NF_kB Signaling and Metastatic Potential in Breast Cancer Cells”
by Kanakaraju Manupati, Ritama Paul, Mingang Hao, Michael Haas, Zhaoqun Christine Bian, Tammy M. Holm, Jun-Lin Guan and Syn Kok Yeo
Cancers 2022, 14(2), 455; https://doi.org/10.3390/cancers14020455  
Available online: https://www.mdpi.com/2072-6694/14/2/455

“Molecular Targets of Triple-Negative Breast Cancer: Where Do We Stand?”
by Emma E. Newton, Lauren E. Mueller, Scout M. Treadwell, Cindy A. Morris and Heather L. Machado
Cancers 2022, 14(3), 482; https://doi.org/10.3390/cancers14030482  
Available online: https://www.mdpi.com/2072-6694/14/3/482

“The Impact of Estrogens and Their Receptors on Immunity and Inflammation during Infection”
by Alfred T. Harding and Nicholas S. Heaton
Cancers 2022, 14(4), 909; https://doi.org/10.3390/cancers14040909  
Available online: https://www.mdpi.com/2072-6694/14/4/909

“Current Limitations and Novel Perspectives in Pancreatic Cancer Treatment”
by Steve Robatel and Mirjam Schenk
Cancers 2022, 14(4), 985; https://doi.org/10.3390/cancers14040985  
Available online: https://www.mdpi.com/2072-6694/14/4/985

“Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials”
by Lars Tramsen, Konrad Bochennek, Monika Sparber-Sauer, Emilia Salzmann-Manrique, Monika Scheer, Tobias Dantonello, Arndt Borkhardt, Uta Dirksen, Anne Thorwarth, Jeanette Greiner et al.
Cancers 2023, 15(7), 2050; https://doi.org/10.3390/cancers15072050
Available online: https://www.mdpi.com/2072-6694/15/7/2050

“The Cell Biology of Metastatic Invasion in Pancreatic Cancer: Updates and Mechanistic Insights”
by Vidhu B. Joshi, Omar L. Gutierrez Ruiz and Gina L. Razidlo
Cancers 2023, 15(7), 2169;  https://doi.org/10.3390/cancers15072169
Available online: https://www.mdpi.com/2072-6694/15/7/2169

“Spatial Transcriptomics Identifies Expression Signatures Specific to Lacrimal Gland Adenoid Cystic Carcinoma Cells”
by Acadia H. M. Moeyersoms, Ryan A. Gallo, Michelle G. Zhang, Vasileios Stathias, Michelle M. Maeng, Dawn Owens, Rayan Abou Khzam, Yoseph Sayegh, Cynthia Maza, Sander R. Dubovy et al.
Cancers 2023, 15(12), 3211; https://doi.org/10.3390/cancers15123211  
Available online: https://www.mdpi.com/2072-6694/15/12/3211

“Antagonizing MDM2 Overexpression Induced by MDM4 Inhibitor CEP-1347 Effectively Reactivates Wild-Type p53 in Malignant Brain Tumor Cells”
by Yuta Mitobe, Shuhei Suzuki, Yurika Nakagawa-Saito, Keita Togashi, Asuka Sugai, Yukihiko Sonoda, Chifumi Kitanaka, and Masashi Okada
Cancers 2023, 15(17), 4326;  https://doi.org/10.3390/cancers15174326  
Available online: https://www.mdpi.com/2072-6694/15/17/4326

“Melanin—The Éminence Grise of Melanoma and Parkinson’s Disease Development”
by Danuta Krasowska, Agata Małek, Joanna Kurzepa, Lucyna Kapka-Skrzypczak, Dorota Krasowska and Jacek Kurzepa
Cancers 2023, 15(23), 5541; https://doi.org/10.3390/cancers15235541  
Available online: https://www.mdpi.com/2072-6694/15/23/5541

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.

Cancers Editorial Office